A Double-blind, Randomized, Placebo Controlled Pilot Trial to Evaluate the Safety and Efficacy of Vorapaxar in Maturation of Arteriovenous Fistulae for Hemodialysis Access
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 28 Jul 2017
At a glance
- Drugs Vorapaxar (Primary)
- Indications Arterial thrombosis; Infections
- Focus Therapeutic Use
- 24 Jul 2017 Planned End Date changed from 1 Feb 2017 to 1 Oct 2018.
- 24 Jul 2017 Planned primary completion date changed from 1 Feb 2017 to 1 Oct 2017.
- 24 Jul 2017 Status changed from not yet recruiting to active, no longer recruiting.